Compugen (CGEN) Liabilities and Shareholders Equity (2009 - 2026)

Compugen has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $145.9 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $145.9 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $506.8 million (up 9.2% YoY), and the FY2025 annual result was $156.6 million, up 36.15% from the prior year.
• Liabilities and Shareholders Equity slipped to $145.9 million in Q1 2026, from $156.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $156.6 million in Q4 2025 and troughed at $67.6 million in Q3 2023.
• A 5-year average of $109.4 million and a median of $110.3 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity slumped 31.96%; it then jumped 82.69% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $94.2 million in 2022, then advanced by 28.84% to $121.3 million in 2023, then slipped by 5.22% to $115.0 million in 2024, then surged by 36.15% to $156.6 million in 2025, then decreased by 6.84% to $145.9 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $145.9 million in Q1 2026, $156.6 million in Q4 2025, and $97.8 million in Q3 2025.